0.2334 0.013 (6.09%) | 11-08 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.38 | 1-year : | 0.46 |
Resists | First : | 0.32 | Second : | 0.4 |
Pivot price | 0.25 | |||
Supports | First : | 0.21 | Second : | 0.17 |
MAs | MA(5) : | 0.23 | MA(20) : | 0.26 |
MA(100) : | 0.33 | MA(250) : | 0.71 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 12 | D(3) : | 13.9 |
RSI | RSI(14): 42.3 | |||
52-week | High : | 1.78 | Low : | 0.18 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MYNZ ] has closed above bottom band by 29.1%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.25 - 0.25 | 0.25 - 0.25 |
Low: | 0.21 - 0.21 | 0.21 - 0.22 |
Close: | 0.23 - 0.23 | 0.23 - 0.23 |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Mon, 21 Oct 2024
Mainz Biomed Highlights Growth and Innovations for 2025 - TipRanks
Fri, 18 Oct 2024
Mainz Biomed Sees Revenue Growth Amid Cost Reductions - TipRanks
Thu, 10 Oct 2024
Mainz Biomed Secures Additional $1.5M Funding - Yahoo Finance
Thu, 03 Oct 2024
Mainz Biomed Executes Convertible Note Agreement - TipRanks
Mon, 23 Sep 2024
Mainz Biomed stock plunges to 52-week low of $0.21 - Investing.com
Thu, 12 Sep 2024
Mainz Biomed stock plunges to 52-week low of $0.3 amid market challenges - Investing.com
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Diagnostics & Research
|
|
Shares Out | -13 (M) |
Shares Float | 0 (M) |
Held by Insiders | 2.559e+007 (%) |
Held by Institutions | 2.209e+007 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -1.12 |
Profit Margin | 0 % |
Operating Margin | -1 % |
Return on Assets (ttm) | 883.2 % |
Return on Equity (ttm) | -99.3 % |
Qtrly Rev. Growth | 333.7 % |
Gross Profit (p.s.) | 123.33 |
Sales Per Share | -3368.89 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -2.159e+007 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | -0.22 |
Price to Sales | -0.01 |
Price to Cash Flow | 0 |
Dividend | 1.7e+006 |
Forward Dividend | 720640 |
Dividend Yield | 728363000% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |